Category: Thoratec Corp.
Allergan CEO David Pyott steps down from the board at Edwards Lifesciences to devote more time to his chief executive duties.
, Boston Scientific
, Edwards Lifesciences
, LensAR Inc.
, LifeCell Corp.
, Polaris Industries
, Premier Inc.
, Sensory Medical
, STAAR Surgical Co.
, Thoratec Corp.
, Allergan Inc.
Thoratec ousts CEO Gary Burbach and replaces him with predecessor Keith Grossman.
Thoratec's stock drops more than 26% in after-hours trading after the company lowers its full-year guidance on a dreary 2nd quarter.
Circulatory devices maker Thoratec (NSDQ:THOR) took a major hit yesterday as a bleak 2nd-quarter reports and a lowered outlook on the year sent its stock into a nosedive.
Here's a look at some of the top regulatory stories for medical device companies this week: Covidien taps integration chief to navigate Medtronic merger; Zimmer, Biomet appoint integration team; Thoratec inks $75M deal for Apica Cardiovascular; FTC wants more from Zimmer, Biomet on merger; Johnson & Johnson closes Ortho-Clinical Diagnostics sale
Thoratec pays $35 million up front and puts another $40 million up in milestone payments for Apica Cardiovascular and its transapical access technology.
Thoratec (NSDQ:THOR) said it paid $35 million up front and agreed to another $40 million in potential milestone payments for Apica Cardiovascular and its transapical access technology.
Thoratec says it's launched a clinical trial for its HeartMate III implantable heart pump it plans to useto back a bid for CE Mark approval in the European Union.